News Story Archives - PBD Biotech

Targeting global unmet need for rapid molecular diagnostic for human TB

January 19, 2023

PBD Biotech is announcing that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis (TB) and will be suspending its commercial Johne’s Testing Service.

Targeting global unmet need for rapid molecular diagnostic for human TB

January 19, 2023

PBD Biotech is announcing that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis...

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

January 17, 2023

Identifying those most at risk of active TB disease becomes a priority as fatalities increase. In response to this need, PBD Biotech is announcing that it has appointed Dr Marie Roskrow to chair its board and has expanded its scientific...

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

January 17, 2023

Identifying those most at risk of active TB disease becomes a priority as fatalities increase. In response to this need,...

Words Matter – how a shared language will accelerate development of TB diagnostics

December 21, 2022

Creating a shared language for talking about tuberculosis has been identified by the Stop TB Partnership as being a constructive step towards achieving the United Nations political declaration to eliminate TB by 2030.

Words Matter – how a shared language will accelerate development of TB diagnostics

December 21, 2022

Creating a shared language for talking about tuberculosis has been identified by the Stop TB Partnership as being a constructive...

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

November 22, 2022

Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been revealed by the TAG pipeline report

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

November 22, 2022

Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been...

Improved diagnostics priority in Global Plan to End TB

November 21, 2022

The Global Plan to End TB is a costed public health plan. It aims to cut deaths by 90% in 8 years. A key recommendation of the report is to universally replace sputum microscopy with rapid molecular diagnostics.

Improved diagnostics priority in Global Plan to End TB

November 21, 2022

The Global Plan to End TB is a costed public health plan. It aims to cut deaths by 90% in...

Pictured from left are Ray Harris from Foresight, Sandy Reid of Mercia Asset Management, Jane Theaker of PBD Biotech and Mark Wilcockson of British Business Bank

PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test

October 17, 2022

Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic with potential to revolutionise management of TB.

PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test

October 17, 2022

Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic...

Rapid Research in Diagnostics Development for TB Network R2D2 TB Network

Promising TB diagnostic Actiphage selected for evaluation by R2D2 TB Network

September 30, 2022

Ease of use at the point of need is vital for the roll out of a diagnostic, so PBD Biotech, developers of Actiphage - a rapid blood test for early-stage tuberculosis - is partnering with the Rapid Research in Diagnostics...

Promising TB diagnostic Actiphage selected for evaluation by R2D2 TB Network

September 30, 2022

Ease of use at the point of need is vital for the roll out of a diagnostic, so PBD Biotech,...

Mondana Cook, Chief Operating Officer at PBD Biotech

Mondana Cook joins PBD Biotech to bring human TB diagnostic to market

July 19, 2022

New Chief Operating Officer brings experience of tuberculosis vaccine and precision medicine.

Mondana Cook joins PBD Biotech to bring human TB diagnostic to market

July 19, 2022

New Chief Operating Officer brings experience of tuberculosis vaccine and precision medicine.

Actiphage detects Johne’s disease in vaccinated goat

June 9, 2022

A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that are naturally infected and those vaccinated against Mycobacterium avium subspecies paratuberculosis (MAP), the pathogen that causes Johne’s Disease, supporting the...